# sPLA2 in EBC During Acute Chest Syndrome

> **NCT03250585** · — · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 6 (actual)

## Conditions studied

- Sickle Cell Disease
- Acute Chest Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Exhaled Breath Condensate (EBC)
- **DIAGNOSTIC_TEST:** Plasma Sample

## Key facts

- **NCT ID:** NCT03250585
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-19
- **Primary completion:** 2018-06-14
- **Final completion:** 2018-06-14
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03250585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03250585, "sPLA2 in EBC During Acute Chest Syndrome". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03250585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*